EpiCypher, Inc (The Woodlands, TX, USA) develops and manufacturers novel tools for epigenetics and chromatin biology research, based on the expertise and unique insight of their industry-leading scientific team, who are renowned, experienced chromatin researchers.
Dr. Ali El Bayâ (Sales Manager – Proteins & Protein based Products & Services) says "Epicypher's portfolio will perfectly complement tebu-bio's offer in the emerging field of Epigenetics. On one hand we will explore a new market with Epicypher's Histone Peptide Arrays: hundreds of highly purified histone derived peptides - unmodified and modified and spotted to the array - allowing in-depth interaction studies. On the other hand, Epicypher's native and recombinant nucleosome preparations and epigenetic enzymes will enlarge our offer for screening activities especially in the Drug Discovery environment."
“Our partnership with tebu-bio supports our continued commitment to our customers’ success” stated Jim Bone, President of EpiCypher. “During in-person discussions in Europe with tebu-bio, the opportunity to realize our mutual success became clear. As epigenetics gains importance in the global research field, this partnership will increase our presence in the global market to meet demand and further aid the realization of EpiCypher’s business strategy.”
To find out more about EpiCypher’s products available from tebu-bio, visit http://www.tebu-
About tebu-bio: tebu-bio is an expert in the supply & distribution of Life Sciences Lab Services & Reagents throughout Europe. Their own European based laboratories (http://www.tebu-
About EpiCypher: EpiCypher is a leading epigenetics products and services company that provides research support to leading discovery groups in industry and academia. EpiCypher’s patented EpiGold™ Histone Peptide Array is the most advanced histone array currently available. EpiCypher also sells nucleosomes, recombinant histone binding proteins, peptides and antibodies, as well as peptide synthesis and peptide array screening services. For more information about EpiCypher, visit http://www.epicypher.com.